Employee biomarker screening: what it measures and why

A modern employee biomarker screening measures three things read together: blood biomarkers that reflect metabolic, cardiovascular and inflammatory health (glucose, HbA1c, blood lipids including ApoB, hs-CRP and more), a validated mental-wellbeing survey, and wearable data such as steps, resting heart rate and sleep. The point is not a single number but a fuller picture of preventable risk over time. As förebyggande företagshälsovård, the individual keeps their own detailed results, while the employer only ever sees aggregated, anonymised patterns across the group.

Key takeaways

• A good screening reads three layers together: blood biomarkers, a validated wellbeing survey, and wearable trends (steps, resting heart rate, sleep).
• Common blood markers include glukos, HbA1c, blodfetter, ApoB and hs-CRP — indicators of metabolic, cardiovascular and inflammatory health.
• The employee owns their individual results; the employer sees only aggregated, anonymised data, never one person's numbers.
• Read as förebyggande företagshälsa, the three layers reinforce each other — a wearable trend can explain a blood marker, and a wellbeing signal can explain both.

What the blood biomarkers measure

Blood is the densest single source of preventive signal. A typical panel groups markers by what they tell you. Metabolic: glukos and HbA1c reflect how the body handles blood sugar over days and months — early drift here is one of the most actionable findings in working-age adults. Cardiovascular: a lipid panel plus ApoB gives a clearer read on circulating atherogenic particles than cholesterol alone. Inflammation: hs-CRP is a low-grade inflammation marker linked to long-term cardiovascular and metabolic risk. Around these sit markers of kidney and liver function, blood count, and micronutrients. None of this diagnoses disease — it flags where a person may want to act early and, where relevant, speak to their own doctor.

Why a wellbeing survey belongs in the picture

Physical markers alone miss a large part of workplace health. Stress, sleep quality, mood and perceived recovery shape both long-term biology and short-term sick leave. A screening that includes a validated questionnaire — evidence-led instruments rather than an ad-hoc form — turns subjective experience into something trackable over time. Read alongside blood and wearable data, it can show, for example, that a rising resting heart rate coincides with reported poor sleep and elevated hs-CRP, pointing to a recovery problem rather than three unrelated blips. It is a wellbeing signal, not a clinical diagnosis.

What wearables add

Wearable integration brings the day-to-day layer a blood draw cannot. Steps give a simple proxy for daily movement, resting heart rate trends track cardiovascular fitness and recovery, and sleep patterns underpin nearly every other marker. Because these update continuously, they turn an annual snapshot into an ongoing trend line and help a person see whether a change they made is actually working. Integration is opt-in, and the same privacy rule applies: individual streams stay with the individual.

What employees get, and what employers get

This distinction is the heart of a trustworthy programme. The employee gets their own detailed results, plain-language context on what each marker means, trends over time, and guidance on where to focus — theirs to keep, and theirs to share with a doctor if they choose. The employer gets only aggregated, anonymised insight: group-level themes such as the share of participants with elevated cardiometabolic risk, or reported sleep quality across a large enough cohort to prevent re-identification. An employer never sees an individual's biomarkers, survey answers or wearable data. That separation is what lets a company invest in prevention without becoming a party to anyone's medical information.

Privacy and how it is built

Because this is health data, the technical and legal foundations matter. Pheno is built as medical-device software under EU MDR, with data handling designed around GDPR and EU data residency. Individual results are the individual's; aggregation thresholds and anonymisation sit between raw data and anything an employer can view. Any biological-age figure is presented as an estimate, not a validated diagnostic result. And clinical logic runs with a doctor-in-the-loop rather than as an unsupervised algorithm.

What Pheno can add

Pheno delivers this as the 360: physical blood biomarkers, a validated mental-wellbeing survey and wearable integration (steps, resting heart rate, sleep) read together, with each employee keeping their own results and the employer receiving only aggregated, anonymised insight. It is designed as förebyggande företagshälsovård rather than a standalone perk. See Pheno for companies for how a programme is set up.

Frequently asked questions

Can my employer see my individual results?

No. Employees keep their own detailed results. Employers receive only aggregated, anonymised data across a group large enough to prevent identifying any one person — never an individual's biomarkers, survey answers or wearable streams.

How are the three layers read together?

The value of the 360 is in the overlap. A rising resting heart rate from a wearable, poor reported sleep from the wellbeing survey and an elevated hs-CRP in blood are more informative together than apart — they point to a single recovery problem rather than three unrelated readings. Each layer is captured with the individual's consent and read as one picture for that person.

Does this diagnose disease?

No. A screening flags where risk may be trending and where early action could help; it does not diagnose or treat. Where a finding warrants it, you are encouraged to follow up with your own physician.

Do I have to share my wearable data?

No. Wearable integration is opt-in, and like the rest of your results it stays with you. You can take part in the blood and survey components without connecting a device.

Sources & methodology

This article is general education drawn from public guidance and standard preventive-health practice. For sick-leave and workforce-health statistics, Försäkringskassan and SCB publish national data, and the WHO provides guidance on non-communicable disease prevention. This is not medical advice — confirm your own situation with a qualified professional.

• Försäkringskassan — statistics on sjukfrånvaro and sjukpenning (forsakringskassan.se).
• Statistiska centralbyrån (SCB) — labour-market and health statistics (scb.se).
• World Health Organization (WHO) — guidance on prevention of noncommunicable diseases (who.int).